
    
      The primary objective of this study will be to determine the potential of Diltiazem
      Hydrochloride 2% Cream to cause irritation after repeated topical application to the healthy
      skin of humans under controlled conditions.

      In addition, safety will be assessed by evaluation of any adverse events (AEs) reported
      during the study.
    
  